Consensus AstraZeneca PLC

Equities

AZN

GB0009895292

Delayed London S.E. 12:35:09 2024-03-28 pm EDT 5-day change 1st Jan Change
10,678 GBX -0.60% Intraday chart for AstraZeneca PLC +2.40% +0.74%

Evolution of the average Target Price on AstraZeneca PLC

Price target over the last 5 years

History of analyst recommendation changes

76b6577c079e7b4c.79JN9hDv24P_MEiqETtuHI8jQaPFuQvME9hcQA1Jpdk.hZx-ulGqi-ynZXj_UnYUK70QKdCWym6DIe4IDTkCzoi5oCqfJ6ic4qVjIw~fceac42d00d9ae167a3f9148b66bf0d2
ASTRAZENECA : Deutsche Bank reiterates its Sell rating ZD
ASTRAZENECA : Gets a Sell rating from UBS ZD
B. Riley Downgrades Fusion Pharmaceuticals to Neutral From Buy on Heels of Announced Sale to AstraZeneca, Adjusts PT to $23 From $13 MT
Fusion Pharmaceuticals Downgraded by RBC to Sector Perform From Outperform, Speculative Risk Removed, Price Target Raised to $21 From $16 MT
ASTRAZENECA : UBS reaffirms its Sell rating ZD
ASTRAZENECA : Deutsche Bank keeps a Sell rating ZD
ANALYST RECOMMENDATIONS : Abbvie, Align Technology; Ulta Beauty, United Airlines, Currys... Our Logo
ASTRAZENECA : Buy rating from JP Morgan ZD
Berenberg: AstraZeneca Set for More Lung Cancer Success After Recent Pipeline Gains MT
ASTRAZENECA : Deutsche Bank reiterates its Sell rating ZD
Berenberg Trims AstraZeneca PT, Maintains Buy Rating MT
JPMorgan cuts Airtel Africa price target by 28% AN
ASTRAZENECA : Berenberg reiterates its Buy rating ZD
ASTRAZENECA : UBS keeps a Sell rating ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating ZD
ASTRAZENECA : Jefferies reiterates its Neutral rating ZD
ASTRAZENECA : JP Morgan remains its Buy rating ZD
DZ Bank Lowers AstraZeneca's Fair Value, Keeps Hold Rating MT
Citi lifts GSK; Shore likes XPS Pensions AN
BMO Capital Cuts AstraZeneca's Price Target to $80 From $82, Outperform Rating Maintained MT
ASTRAZENECA : DZ Bank sticks Neutral ZD
Stifel Reduces AstraZeneca PT, Keeps Buy Rating MT
ASTRAZENECA : UBS lowers target price CF
AstraZeneca: further decline after two negative analyses CF
ASTRAZENECA : price target lowered by Barclays CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
135 USD
Average target price
158.5 USD
Spread / Average Target
+17.39%
High Price Target
212.2 USD
Spread / Highest target
+57.17%
Low Price Target
119.9 USD
Spread / Lowest Target
-11.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AstraZeneca PLC

DEUTSCHE BANK RESEARCH Emmanuel Papadakis
UBS Matthew Weston
RBC Capital Markets
B. Riley
JPMORGAN James Gordon
Berenberg Bank
BERENBERG Luisa Hector
JEFFERIES Peter Welford
DZ Bank
BMO Capital
Stifel Nicolaus
BARCLAYS Emily Field
Deutsche Bank Securities
alphavalue Abhishek Raval
Jefferies & Co.
CREDIT SUISSE Dominic Lunn
HSBC
Argus
Morgan Stanley
GOLDMAN SACHS Keyur Parekh
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA) Sachin Jain
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings